Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
NIH Grants & Funding for Neoplasm of Mature B-Cells | Kisho | Kisho
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Neoplasm of Mature B-Cells. Strongest funded area: Epidemiology / Natural History. Largest gap: Basic Science.
Clinical ResearchTrials Active, No NIH Grants
2 clinical trials registered but no NIH-funded clinical or translational research grants found for neoplasm of mature B-cells. Trials may be industry-sponsored or funded through non-NIH sources.
Biomarker / DiagnosticsPublished, Not NIH-Funded
11 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for neoplasm of mature B-cells. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
9 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for neoplasm of mature B-cells. Existing research activity suggests this may be a viable area for grant applications.
Basic SciencePublished, Not NIH-Funded
58 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for neoplasm of mature B-cells. Existing research activity suggests this may be a viable area for grant applications.
Translational / Drug DevelopmentPublished, Not NIH-Funded
23 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for neoplasm of mature B-cells. Existing research activity suggests this may be a viable area for grant applications.
